KTKateryna Tarianyk

Kateryna Tarianyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kateryna Tarianyk has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Secondary hyperkalemic paralysis (clinical case)

    by M. Yu. Delva, I. I. Delva, V. A. Pinchuk, G. Ya. Sylenko, K. A. Tarianyk, K. V. Hryn, T. Yo. Purdenko, A. M. Kryvchun, A. D. Shkodina

    Background. Secondary hyperkalemic paralysis (SHP) is a specific and rare manifestation of hyperkalemia characterized by acute (subacute) symmetrical flaccid paresis. If SHP is not recognized promptly, the further progression of hyperkalemia can lead to the development of fatal cardiac arrhythmias and respiratory failure. Purpose – presentation of a clinical case of SHP. Materials and Methods. A clinical case of SHP in the form of transient lower paraplegia in a patient with newly diagnosed multiple myeloma complicated by acute nephropathy is reported. Results. A 53-year-old male patient was admitted to the emergency department complaining of a lack of movement in his lower limbs. About 6 hours ago, he suddenly experienced weakness in both lower limbs, and about 2 hours ago, movement in both legs disappeared. There is no active movement in both lower limbs, but muscle strength in the upper limbs is normal. Muscle tone in the upper limbs is normal, but significantly reduced in the lower limbs. Deep reflexes in the upper limbs are reduced and symmetrical, but absent in the lower limbs. No pyramidal symptoms, sensory and coordination disorders, meningeal symptoms were detected. ECG: sinus bradycardia 51/min, high-pointed T waves, widened QRS complexes. Biochemical blood analysis: creatinine – 3295.3 μmol/L (70–115), urea – 76.4 mmol/L (<8.3), potassium – 9.4 mmol/L (3.3–5.5), calcium – 3.07 mmol/L (2.15–2.55). On the same day, during acute hemodialysis, the patient began to move his lower limbs. The next day, strength in the legs was fully restored, and serum potassium was 6.05 mmol/L. Conclusions. In cases of acute (subacute) tetraparesis or lower paraparesis, SHP should be ruled out, especially in patients with kidney disease.

  • Open Access

    Chronic inflammatory axonal polyneuropathy (clinical case report, discussion)

    by M.YU. Delva, I.I. Delva, V.A. Pinchuk, K.A. Tarianyk, H.YA. Sylenko, T.Y. Purdenko, A.M. Kryvchun, K.V. Hryn

    The purpose was to demonstrate the significance of knowledge of diagnostic criteria for rare types of polyneuropathy among neurologists by describing a clinical case of chronic inflammatory axonal polyneuropathy. Female patient V., 51 years old, complained of unpleasant sensations in both feet and lower legs, weakness in the legs, and walking difficulties. She has been suffering for 4 months since she noticed burning sensations in her feet for no obvious reason. The patient has repeatedly sought medical help from family doctor, neurologists. She was diagnosed with idiopathic polyneuropathy of the lower extremities, for which repeatedly underwent outpatient and inpatient treatment. Despite this, discomfort in her feet increased, and she began to experience leg fatigue and walking difficulties. At the initial examination, peripheral lower distal moderate paraparesis, decreased pain and tactile sensitivity in the feet and the distal parts of the lower leg, impaired muscle-joint and vibration sensitivity in the toes were detected. Gait was paraparetic with ataxia. The following findings were revealed during additional examinations: high levels of cyanocobalamin in the blood (the patient was taking vitamin B12), primary axonal type of nerve fiber lesions by electroneuromyography, and elevated protein levels in the cerebrospinal fluid. Diagnosis was chronic inflammatory axonal polyneuropathy with mode­rate distal paraparesis of the lower extremities, sensory ataxia. The following treatment was prescribed: prednisolone 60 mg per day, omeprazole, and spironolactone. At the end of the second week of taking prednisolone, the patient noticed a decrease in unpleasant sensations in her legs and improved walking. After 2 months, the dysesthesia in her legs completely disappeared, muscle strength in the legs was restored, and walking was normalized. At the follow-up examination, full restoration of strength in the leg muscles, of muscle-joint sensation in the toes, and vibration sensitivity in the feet were noted. Neurologists need to be aware of and use diagnostic criteria for chronic inflammatory axonal polyneuropathy to ensure adequate treatment.

  • Open Access

    The renal-brain axis and neuropsychological disorders: an analysis of the relationship

    by V.A. Pinchuk, M.YU. Delva, K.V. Hryn, V.V. Bilko, I.I. Delva, T.I. Purdenko, K.A. Tarianyk

    Impaired cognitive function is known to be one of the leading causes of disability among the population, and the number of patients in need of long-term rehabilitation aimed at restoring mental health is increasing. Recently, there has been a marked increase in the interest of doctors of various specialties in studying the relationship between the somatic and nervous systems of the body and the clinical features of nervous system damage in visceral diseases. In particular, the study of nephrogenic nervous system lesions, which lead to a decrease in the quality of life of patients and significant financial costs, remains relevant and determines the importance of this medical and social problem. Cognitive impairment is diagnosed in the early stages of the disease and progresses in parallel with the decline in renal function. Oxidative stress, endothelial dysfunction, accelerated arteriosclerosis and uremic inflammatory environment affect both the central and peripheral nervous system. Understanding the interaction between the kidneys and the brain is an interdisciplinary problem in the scientific field. This paper analyses the current literature sources from the Scopus, Web of Science, MedLine, PubMed, NCBI databases on neuropsychological disorders in patients with kidney disease, presents the most well-known renogenic neuropsychological disorders, their pathogenesis and clinical characteristics. The bibliographic, analytical research methods and the methodology of the systematic approach were used in the study. Patients at all stages of chronic kidney disease are at higher risk of developing dementia and cognitive impairment, and recent epidemiological studies have shown that acute kidney injury is associated with the risk of subsequent stroke and dementia. The publication aims to summarize the existing scientific data on renogenic neuropsychological disorders, demonstrate the importance of evaluating diagnostic criteria and clinical features, and draw the attention of physicians to timely diagnosis, etiopathogenetic treatment and prevention of this pathology based on the study of modern literature. Given the latter, it was found that dysregulation of the renal-brain axis is the cause of neuropsychological disorders, and the poorly studied complex pathogenetic relationship and the exact mechanism of modulation between renal and cognitive disorders requires further analysis, as growth of neuropsychological disorders in the population should be expected.

  • SYNERGISM OF CLINICAL MANIFESTATIONS OF TEMPOROMANDIBULAR JOINT DYSFUNCTION AND MENINGIOMA. DIAGNOSTIC AND THERAPEUTIC CHALLENGES

    by M. A. Korostashova, K. A. Tarianyk, A. I. Pankevych, A. M. Hohol, I. A. Kolisnyk, V. M. Novikov

  • Open Access

    CHRONOTYPE AND DAILY FUNCTIONING OF PATIENTS WITH DIFFERENT MOTOR SUBTYPES OF PARKINSON DISEASE

    by A.D. Shkodina, M. Bardhan, K.A. Tarianyk, M. Yu. Delva

    Introduction. Sleep and circadian rhythm disturbances can occur at any stage of Parkinson disease (PD) and significantly affect quality of life. Chronotypes of patients with PD are associated with different phenotypes, in particular with the motor subtype. Thus, we hypothesized that patients with different motor subtypes of PD may have differences in the distribution of chronotypes and patterns of daily activity. Methods and materials. We conducted clinical research on the basis of the Centre for Parkinson Disease and Neurodegenerative Diseases of the Department of Neurological Diseases of Poltava State Medical University. PD was verified according to the recommendations of the International Movement Disorders and Parkinson's Disease Society. The motor subtype of PD was determined by the Stebbin method, which is based on the calculation of the Stebbins coefficient by the sum of the Unified PD Rating Scale scores. The examined patients were divided into 3 groups according to the motor subtype of PD: group 1 (n = 38) - patients with PD subtype with the predominance of postural instability and gait disorders (PIGD); group 2 (n = 26) - patients with PD subtype with the predominance of tremor and mixed subtype; control group (n = 30) - conditionally healthy individuals without CNS lesions. Circadian patterns were analyzed using the Munich Chronotype Questionnaire (MCTQ). Results. It was found that in PD patients sleep onset and time of getting out of bed was later (p<0.001 and p=0.042, respectively), sleep latency was longer (p<0.001), sleep duration was shorter (p=0.001), the mid-sleep corresponded to a later time (p<0.001). Patients with the PIGD subtype had a later time of getting out of bed (p=0.038), longer sleep inertia (p<0.001), shorter sleep duration (p<0.001), and later mid-sleep time (p=0.028). We have shown the tendency of patients with PD, mostly in the PIGD subtype, to later chronotypes (p<0.001). Light exposure indirectly moderately correlated with mid-sleep in all study groups. It was found that both the motor subtype (p<0.001) and the level of light exposure during the day (p<0.001) statistically significantly affect the mid-sleep. Conclusion. Thus, we have found that patients with PD differ from age-matched controls without neurodegenerative diseases by chronotype and circadian pattern of functioning. The motor subtype of the disease is associated with circadian differences, namely, the PIGD subtype is associated with shorter sleep duration, a predisposition to a later chronotype, and longer sleep inertia.

  • Open Access

    PROGNOSTIC VALUES OF CIRCADIAN RHYTHM AND SLEEP PARAMETERS IN ASSESSMENT OF STATE ANXIETY IN PARKINSON’S DISEASE WITH REGARD TO MOTOR SUBTYPE

    by Anastasiia Shkodina, Kateryna Tarianyk, Mykhailo Delva

    Introduction. Parkinson’s disease is characterized by motor and non-motor symptoms, the connection between which has recently attracted much attention from researchers. Sleep disturbances and anxiety can be non-motor signs of Parkinson’s disease. The specificity of non-motor symptoms in different motor subtypes is being actively studied, with the PIGD (postural instability and gait difficulty) subtype being associated with more severe non-motor symptoms. Methods. We conducted a clinical monocentric cross-sectional study that included 64 patients with Parkinson’s disease. Patients were assessed according to the Unified Parkinson’s Disease Rating Scale, and their motor subtype was determined by calculations using the method of Jankovich and Stebbins. We assessed circadian rhythm using the Ukrainian version of the Munich Chronotype Questionnaire, sleep quality – using the Pittsburgh Sleep Quality Index, excessive daytime sleepiness – using the Epworth Sleepiness Scale, and state anxiety – using the first block of the State-Trait Anxiety Inventory. Results. Our sample consisted of approximately equal numbers of men and women with a mean age of 63.80 ± 9.30 years. All patients were approximately equally distributed by motor subtype and sleep quality. At the same time, our sample was dominated by patients with a high level of state anxiety, morning chronotype, and the absence of excessive daytime sleepiness. State anxiety demonstrated a moderate direct correlation with sleep latency, mid-sleep, subjective sleep quality, subjective sleep latency, sleep disturbance, and total score of Pittsburgh Sleep Quality Index and a moderate indirect association with average weekly light exposure. It was found that an increased mid-sleep time, a decreased average weekly light exposure during the day, poor sleep quality, and PIGD subtype elevated the odds of more severe situational anxiety. Conclusions. Our study demonstrates the relationship between the level of situational anxiety and parameters of sleep and circadian rhythm in patients with Parkinson’s disease, considering their motor subtype. It was found that a later mid-sleep, lower average weekly light exposure, poor sleep quality, and PIGD subtype of Parkinson’s disease had a prognostic role regarding the increase in state anxiety

  • Ghrelin as a biomarker of non-motor symptoms and sleep disorders at Parkinson's disease

    by Kateryna Tarianyk, Nataliya Lytvynenko, Halyna Silenko, Olena Palenka

    Among the movement disorders characterized by Parkinson's disease, an equally important component is non-motor symptoms. To date, the neurophysiological basis of development and potential biomarkers of the disease remain insufficiently studied. The purpose of our study is to analyze the possibility of using the level of ghrelin in blood plasma as a biomarker of non-motor symptoms and sleep disturbances in Parkinson's disease depending on circadian rhythms. We examined 64 patients with Parkinson's disease registered at the Center for Parkinson's Disease and Other Neurodegenerative Diseases, Department of Nervous Diseases, Poltava State Medical University, and 30 patients without signs of neurodegenerative disease. The diagnosis was established according to the criteria of the World Brain Bank of Great Britain. Non-motor manifestations were studied according to the results of the non-motor symptom assessment scale, the severity of sleep disorders was assessed according to the sleep scale at Parkinson's disease. Results. In the course of the study, a decrease in the level of ghrelin in the blood plasma and the connection of the ghrelin content with sleep and digestive system disorders in patients with Parkinson's disease were established. patients, which is consistent with other studies. Ghrelin stimulates motility and emptying of the stomach, as well as motility of the small and large intestines. This indicates the probable role of ghrelin in the pathophysiology of diseases of the digestive system at Parkinson's disease. Conclusions. The level of plasma ghrelin in patients with Parkinson's disease and its diurnal fluctuations can be considered as a potential biomarker of non-motor symptoms and their fluctuations due to its links with sleep disorders and circadian rhythm.

  • Open Access

    INFLUENCE OF SLEEP DISTURBANCES ON COGNITIVE DECLINE IN PATIENTS WITH PARKINSON’S DISEASE

    by Anastasiia Shkodina, Kateryna Tarianyk, Dmytro Boiko

    The article summarizes the arguments and counter-arguments within the scientific discussion on the impact of sleep disorders on the development of cognitive decline in patients with Parkinson's disease. The main purpose of the study is to study the possibility of predicting the development of cognitive decline by assessing the severity of sleep disorders and their differences in the presence of cognitive impairment. Systematization of literature sources and approaches to solving the problem showed that sleep disorders develop in the early stages of Parkinson's disease and are often accompanied by cognitive impairment. Cognitive decline is manifested throughout Parkinson's disease and ranges from moderate in the early stages to dementia in the late stages. The relevance of the study of the relationship between sleep disorders and cognitive functions lies in the possibility of further improving the prediction of the development of cognitive decline in order to effectively correct it. Treatment of sleep disorders can be accompanied by improved memory and even morphological changes in the brain. Therefore, the question arises about the possibility of correcting cognitive decline by influencing sleep disorders. The methodology of the study included assessment of the overall status of patients on a unified scale of Parkinson's disease, Montreal cognitive rating scale and sleep scale in Parkinson's disease. The duration of the study was 8 months. Patients with Parkinson's disease were selected as the study. The article presents the results of a survey of patients who show that patients with Parkinson's disease and cognitive decline showed a predominance of motor disorders, sleep disorders and the overall score on the sleep scale in Parkinson's disease. In the presence of cognitive decline more pronounced disorders of motor functions in everyday life, which can lead to sleep disorders and its quality. The study empirically confirms and theoretically proves that the assessment of sleep disorders can be used to predict the risk of developing cognitive impairment in patients with Parkinson's disease. The results of this study may be useful for improving the early diagnosis and prevention of cognitive impairment in patients with Parkinson's disease, which, in turn, leads to improved quality of treatment of these patients. Such changes can directly affect the choice of therapeutic tactics and improve the quality of life of patients with Parkinson's disease. The question of the features of various sleep disorders and their prognostic value in relation to cognitive decline in patients with various forms of Parkinson's disease remains open. Стаття узагальнює аргументи та контраргументи в межах наукової дискусії з питання впливу розладів сну на розвиток когнітивного зниження у пацієнтів з хворобою Паркінсона. Основною метою проведеного дослідження є вивчення можливості прогнозування розвитку когнітивного зниження шляхом оцінки вираженості розладів сну та їх відмінності при наявності порушення когнітивних функцій. Систематизація літературних джерел та підходів до вирішення проблеми засвідчила, що розлади сну розвиваються на ранніх етапах хвороби Паркінсона та часто супроводжують когнітивні порушення. Когнітивне зниження виявляється протягом усього періоду хвороби Паркінсона і варіює від помірних на ранніх стадіях, до деменції - на пізніх. Актуальність дослідження взаємозв’язку розладів сну та когнітивних функцій полягає у можливості подальшого удосконалення прогнозування розвитку когнітивного зниження з метою його ефективної корекції. Лікування порушень сну може супроводжуватися покращенням пам'яті і навіть морфологічними змінами головного мозку. Тому постає питання можливості корекції когнітивного зниження шляхом впливу на розлади сну. Методика проведення дослідження включала оцінку загального статусу пацієнтів за уніфікованою шкалою хвороби Паркінсона, монреальською когнітивною оціночною шкалою та шкалою сну при хворобі Паркінсона. Тривалість дослідження складала 8 місяців. Об’єктом дослідження обрано пацієнтів з хворобою Паркінсона. В статті представлено результати обстеження хворих, які засвідчують, що у пацієнтів із хворобою Паркінсона та когнітивним зниженням виявлено переважання моторних розладів, порушення сну та загального балу за шкалою сну при хворобі Паркінсона. При наявності когнітивного зниження більш виражені порушення моторних функцій у повсякденному житті, що можуть...


  • PARRY-ROMBERG SYNDROME: DIFFICULTIES OF DIAGNOSIS AND IMPROVEMENT OF TREATMENT

    by V.M. Hladka, T.Y. Purdenko, K.A. Tarianyk

    The article described a case of a rare disease – progressive facial hemiatrophy in a patient of the Neurological Department of Poltava Regional Clinic